Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1

Cancer Research

Volumn 69, Issue 15, 2009, Pages 6092-6099

  Bousquet, Emilie ^a,b,c   Mazières, Julien ^a,b,c,d   Privat, Maud ^a,b,c   Rizzati, Virginie ^a,b,c   Casanova, Anne ^a,b,c   Ledoux, Adeline ^a,b,c   Mery, Eliane ^c   Couderc, Bettina ^b,c   Favre, Gilles ^a,b,c   Pradines, Anne ^a,b,c  

^a INSERM   (France)

^b France   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d SERVICE DE PNEUMOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAC1 PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; BRONCHUS; CANCER GROWTH; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE;

ANIMALS; BRONCHI; CELL GROWTH PROCESSES; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DOWN-REGULATION; ENZYME ACTIVATION; EPITHELIAL CELLS; FEMALE; HUMANS; LUNG NEOPLASMS; MESODERM; MICE; MICE, NUDE; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS P21(RAS); RAC1 GTP-BINDING PROTEIN; RHOB GTP-BINDING PROTEIN;

EID: 68049144964     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4147     Document Type: Article

References (39)

1. Ellenbroek SI, Collard JG. Rho GTPases: functions and association with cancer. Clin Exp Metastasis 2007;24: 657-672
2. Kamai T, Arai K, Tsujii T, Honda M, Yoshida K. Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour. BJU Int 2001;87:227-231 (Pubitemid 32142533)
3. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000;406:532-535
4. Huang M, Prendergast GC. RhoB in cancer suppression. Histol Histopathol 2006;21:213-218
5. Mazieres J, Antonia T, Daste G, et al. Loss of RhoB expression in human lung cancer progression. Clin Cancer Res 2004;10:2742-2750 (Pubitemid 38509150)
6. Mazieres J, Tillement V, Allal C, et al. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells. Exp Cell Res 2005; 304:354-364 (Pubitemid 40321115)
7. Chen Z, Sun J, Pradines A, Favre G, Adnane J, Sebti SM. Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation, induce apoptosis and suppress human tumor growth in nude mice. J Biol Chem 2000;275:17974-17978 (Pubitemid 30414742)
8. Jiang K, Delarue FL, Sebti SM. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation. Oncogene 2004;23:1136-1145
9. Jiang K, Sun J, Cheng J, Djeu JY, Wei S, Sebti S. Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis. Mol Cell Biol 2004;24:5565-5576 (Pubitemid 38738186)
10. Liu AX, Rane N, Liu JP, Prendergast GC. RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Mol Cell Biol 2001;21:6906-6912 (Pubitemid 32911251)
11. Adnane J, Muro-Cacho C, Mathews L, Sebti SM, Munoz-Antonia T. Suppression of rho B expression in invasive carcinoma from head and neck cancer patients. Clin Cancer Res 2002;8:2225-2232 (Pubitemid 34753594)
12. Forget MA, Desrosiers RR, Del M, et al. The expression of rho proteins decreases with human brain tumor progression: potential tumor markers. Clin Exp Metastasis 2002;19:9-15.
13. Wang S, Yan-Neale Y, Fischer D, et al. Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line. Oncogene 2003;22:6204-6213 (Pubitemid 37281650)
14. Sato N, Fukui T, Taniguchi T, et al. RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line. Int J Cancer 2007;120:543-551 (Pubitemid 44969025)
15. Hara S, Nakashiro K, Goda H, Hamakawa H. Role of Akt isoforms in HGF-induced invasive growth of human salivary gland cancer cells. Biochem Biophys Res Commun 2008;370:123-128
16. Couderc B, Pradines A, Rafii A, et al. In vivo restoration of RhoB expression leads to ovarian tumor regression. Cancer Gene Ther 2008;15:456-464
17. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003;77:8957-8961 (Pubitemid 36936105)
18. Delenda C. Lentiviral vectors: optimization of packaging, transduction and gene expression. J Gene Med 2004;6 Suppl 1:S125-38. (Pubitemid 40228022)
19. Irie HY, Pearline RV, Grueneberg D, et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 2005;171: 1023-1034 (Pubitemid 41815834)
20. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 2005;20:539-550 (Pubitemid 41668639)
21. Mazieres J, Tovar D, He B, et al. Epigenetic regulation of RhoB loss of expression in lung cancer. BMC Cancer 2007;7:220. (Pubitemid 351201645)
22. Liu JP, Jessell TM. A role for rhoB in the delamination of neural crest cells from the dorsal neural tube. Development 1998;125:5055-5067 (Pubitemid 29026786)
23. Vignal E, de Santa Barbara P, Guemar L, Donnay JM, Fort P, Faure S. Expression of RhoB in the developing Xenopus laevis embryo. Gene Expr Patterns 2007;7:282-288 (Pubitemid 44835280)
24. Henderson DJ, Ybot-Gonzalez P, Copp AJ. RhoB is expressed in migrating neural crest and endocardial cushions of the developing mouse embryo. Mech Dev 2000;95:211-214 (Pubitemid 30440808)
25. Wheeler AP, Ridley AJ. RhoB affects macrophage adhesion, integrin expression and migration. Exp Cell Res 2007;313:3505-3516
26. Allal C, Pradines A, Hamilton AD, Sebti SM, Favre G. Farnesylated RhoB prevents cell cycle arrest and actin cytoskeleton disruption caused by the geranylgeranyltransferase I inhibitor GGTI-298. Cell Cycle 2002;1:430-437
27. Wang L, Yang L, Luo Y, Zheng Y. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells. J Biol Chem 2003;278:44617-44625 (Pubitemid 37377216)
28. Hendrix MJ, Seftor EA, Chu YW, Trevor KT, Seftor RE. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev 1996;15:507-525 (Pubitemid 27067169)
29. Kajiyama H, Shibata K, Terauchi M, et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol 2007; 31:277-283
30. Meriane M, Mary S, Comunale F, Vignal E, Fort P, Gauthier-Rouviere C. Cdc42Hs and Rac1 GTPases induce the collapse of the vimentin intermediate filament network. J Biol Chem 2000;275:33046-33052 (Pubitemid 30797086)
31. Minard ME, Ellis LM, Gallick GE. Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clin Exp Metastasis 2006;23:301-313 (Pubitemid 44777570)
32. Jeong HW, Nam JO, Kim IS. The COOH-terminal end of R-Ras alters the motility and morphology of breast epithelial cells through Rho/Rho-kinase. Cancer Res 2005;65:507-515
33. Thiery J. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2006;15:740-746
34. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006;66: 8319-8326 (Pubitemid 44449137)
35. Higuchi M, Masuyama N, Fukui Y, Suzuki A, Gotoh Y. Akt mediates Rac/Cdc42-regulated cell motility in growth factor-stimulated cells and in invasive PTEN knockout cells. Curr Biol 2001;11:1958-1962 (Pubitemid 33146422)
36. Zhou GL, Zhuo Y, King CC, Fryer BH, Bokoch GM, Field J. Akt phosphorylation of serine 21 on Pak1 modulates Nck binding and cell migration. Mol Cell Biol 2003;23:8058-8069 (Pubitemid 37377498)
37. Ackah E, Yu J, Zoellner S, et al. Akt1/protein kinase Ba is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest 2005;115:2119-2127 (Pubitemid 41134153)
38. Arboleda MJ, Lyons JF, Kabbinavar FF, et al. Overexpression of AKT2/protein kinase Bh leads to up-regulation of h1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 2003;63:196-206.
39. Zinda MJ, Johnson MA, Paul JD, et al. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon. Clin Cancer Res 2001;7: 2475-2479